Checkpoint Therapeutics, Inc. (CKPT)
4.260
0.00 (0.00%)
Inactive · Last trade price on May 29, 2025

Checkpoint Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.040.040.10.190.271.07
Revenue Growth
-39.71%-60.19%-46.35%-28.36%-74.93%-37.41%
Gross Profit
-36.11-36.11-43.46-49.63-48.19-15.28
Operating Income
-56.38-56.17-52.15-58.33-56.72-23.2
Net Income
-56.51-56.24-51.85-62.62-56.67-23.08
Earnings Per Share
-1.22-1.42-1.87-6.09-6.70-4.13
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
33.046.64.9312.0754.7440.77
Total Debt
------
Net Cash (Debt)
33.046.64.9312.0754.7440.77
Net Cash Growth
193.94%34.01%-59.16%-77.95%34.25%56.35%
Net Cash Per Share
0.710.170.181.176.477.30

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
--31.1-47.59-57.55-26.31-16.55
Free Cash Flow
--31.1-47.59-57.55-26.31-16.55
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Margin
-137500.00%-137009.76%-50629.13%-30381.77%-21165.30%-2170.35%
Pretax Margin
-137821.95%-137170.73%-50336.89%-32616.67%-21145.52%-2159.12%
Profit Margin
-137821.95%-137170.73%-50336.89%-32616.67%-21145.52%-2159.12%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
8703.263811.32523.05272.85972.14168.28